Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Sleep Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep
0.00 credit

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Incremental Healthcare Burden of Insomnia among Alzheimer’s Disease Patients with and without Underlying Depression
Zaina Qureshi
07:00 AM - 05:00 PM EDT Abstract 002 - Exploratory Study of Acoustic Neuromodulation Improves Caregiver Burden, Insomnia, Stress, Anxiety, and Autonomic Function
Charles H. Tegeler, MD
07:00 AM - 05:00 PM EDT Abstract 003 - Factors associated with insomnia in the Peruvian population during social isolation due to the COVID-19 pandemic
07:00 AM - 05:00 PM EDT Abstract 004 - How Chronic Nausea/Vomiting Worsen Restorative Quality of Sleep in a Longitudinal Study of the American General Population
Maurice M. Ohayon, MD, PhD, DSc
07:00 AM - 05:00 PM EDT Abstract 005 - Insomnia treatments and on-the-road driving performance: a systematic literature review
Genevieve Meier
07:00 AM - 05:00 PM EDT Abstract 006 - A Pilot, Placebo-controlled Trial of Closed-loop Acoustic Stimulation Neurotechnology for Insomnia
Charles H. Tegeler, MD
07:00 AM - 05:00 PM EDT Abstract 007 - Evaluation of Next-Dose Transition from Zolpidem to Lemborexant for the Treatment of Insomnia: A Multicenter Open-label Pilot Study
Russell Rosenberg
07:00 AM - 05:00 PM EDT Abstract 008 - Effect of Lemborexant on Fatigue Severity and Sleep Outcomes Over 12 Months in Subjects With Clinically Significant Fatigue at Baseline
Craig Chepke
07:00 AM - 05:00 PM EDT Abstract 009 - Responder Profiles Over 12 Months for Sleep Onset and Sleep Maintenance Outcomes with Lemborexant
Gary Zammit
07:00 AM - 05:00 PM EDT Abstract 010 - Effect of Lemborexant on Patient-Reported Distress About Sleeping and Interference with Daily Functioning in Subjects With Insomnia
Craig Chepke
07:00 AM - 05:00 PM EDT Abstract 011 - Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation
Michael J. Thorpy, MD
07:00 AM - 05:00 PM EDT Abstract 012 - Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation
Yves Dauvilliers, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 013 - Lower-Sodium Oxybate Dose Titration and Transition From Sodium Oxybate in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adult Participants With Narcolepsy With Cataplexy
Nancy R. Foldvary-Schaefer, DO, FAAN
07:00 AM - 05:00 PM EDT Abstract 014 - Cataplexy-Free Days in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Narcolepsy With Cataplexy
Yves Dauvilliers, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 015 - Time to Onset of Clinical Response During Treatment With Pitolisant
Craig Davis, PhD
07:00 AM - 05:00 PM EDT Abstract 016 - Cardiac Safety Profile of Pitolisant in Patients With Narcolepsy
William C. Winter
07:00 AM - 05:00 PM EDT Abstract 017 - Safety and efficacy of TAK-925 in adults with obstructive sleep apnea who experience excessive daytime sleepiness despite adequate use of CPAP
Richard K. Bogan, MD
07:00 AM - 05:00 PM EDT Abstract 018 - The role of marriage and sleep efficiency in cognitive decline: Results from Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Natalia Rincon, MD
07:00 AM - 05:00 PM EDT Abstract 019 - Subjective sleep disturbances are not associated with objective cognitive functional impairment in Parkinson’s disease
Samantha K. Holden, MD, MS, FAAN
07:00 AM - 05:00 PM EDT Abstract 020 - Evaluating Closed-loop Auditory Stimulation during Sleep as an Intervention to Improve Memory Consolidation
Bryan Baxter, PhD
07:00 AM - 05:00 PM EDT Abstract 021 - Supine Sleep, Sleep Apnea and Sleep Architecture: A Cross-sectional Study in Adults
Kathy K. Xiong, MD
07:00 AM - 05:00 PM EDT Abstract 022 - Association of Mild vs Moderate REM Predominant OSA with Prevalence of Various Cardiovascular, Cerebrovascular Comorbidities: A Retrospective Analysis of Data From Sleep Laboratory at Cabell Huntington Hospital, WV.
Dipali P. Nemade, MD
07:00 AM - 05:00 PM EDT Abstract 023 - Strengthening Oropharyngeal Muscles as a Novel Approach to Treat Obstructive Sleep Apnea after Stroke: A Randomized Feasibility Study
Reeman Marzouqah, MSc
07:00 AM - 05:00 PM EDT Abstract 024 - Diagnostic Thresholds for REM Sleep Without Atonia in Idiopathic/Isolated REM Sleep Behavior Disorder in the North American Prodromal Synucleinopathy (NAPS) Cohort
John C. Feemster, MD
07:00 AM - 05:00 PM EDT Abstract 025 - Chronic Nausea/Vomiting as a Risk Factor for Restless Legs Syndrome in a Longitudinal Study of the American General Population
Maurice M. Ohayon, MD, PhD, DSc
07:00 AM - 05:00 PM EDT Abstract 026 - Association between lower limb post-fracture pseudoarthrosis and restless legs syndrome
Joaquin Ojeda, MD
07:00 AM - 05:00 PM EDT Abstract 027 - Medical Treatment Options for Periodic Limb Movement Disorder and Restless Leg in the Pediatric Population.
Nicole Goldberg-Boltz
07:00 AM - 05:00 PM EDT Abstract 028 - Cytokines in the Central Disorders of Hypersomnolence
Caroline Maness, MD
07:00 AM - 05:00 PM EDT Abstract 029 - The Epworth Sleepiness Scale in Epilepsy: Internal Consistency and Disease-Related Associations
Maeve M. Pascoe
07:00 AM - 05:00 PM EDT Abstract 030 - Atypical Sleep Architecture in Children with 15q11.2-13.1 Duplication (Dup15q) Syndrome
Vidya Saravanapandian, MS
Faculty Disclosures
Natalia Rincon, MD Dr. Rincon has nothing to disclose.
Dipali P. Nemade, MD Dr. Nemade has nothing to disclose.
Wassim Tarraf No disclosure on file
Kiran P. Maski, MD An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
No disclosure on file
David R. Colelli, MSc Mr. Colelli has nothing to disclose.
Carlos Perdomo No disclosure on file
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Amelie Pelletier Ms. Pelletier has nothing to disclose.
Russell Rosenberg Mr. Rosenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Mr. Rosenberg has received research support from Neurotrials Research.
Paul B. Ferguson, MD, FAAN Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Trevor Jairam, MD Trevor Jairam has nothing to disclose.
Bryan Baxter, PhD Dr. Baxter has received research support from American Academy of Neurology/American Brain Foundation/The McKnight Brain Research Foundation.
Jianwen Cai No disclosure on file
Vidya Saravanapandian, MS Miss Saravanapandian has nothing to disclose.
Margaret Moline Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Laavanya Dharmakulaseelan, MD Ms. Dharmakulaseelan has nothing to disclose.
Ariana Stickel No disclosure on file
Hossam A. Shaltout, PhD Dr. Shaltout has nothing to disclose.
Vikram Shivkumar, MD, FAAN Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Gary Zammit Gary Zammit has received personal compensation for serving as an employee of Clinilabs, Inc.. Gary Zammit has received stock or an ownership interest from Clinilabs, Inc. Gary Zammit has received stock or an ownership interest from Sleep Disorders Institute. Gary Zammit has received stock or an ownership interest from Home Sleep and Respiratory Care.
Tina Olsson, PhD Dr. Olsson has received personal compensation for serving as an employee of Takeda.
John C. Feemster, MD Mr. Feemster has nothing to disclose.
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Alberto Ramos, MD, FAAN Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities.
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Kenzie Brown No disclosure on file
Dinesh Kumar No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Madeleine M. Grigg-Damberger, MD Dr. Grigg-Damberger has received personal compensation for serving as an employee of Oxford University Press. Dr. Grigg-Damberger has received personal compensation for serving as an employee of Up-to-date. Dr. Grigg-Damberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Sleep Medicine. Dr. Grigg-Damberger has received publishing royalties from a publication relating to health care.
Reeman Marzouqah, MSc Ms. Marzouqah has nothing to disclose.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Clete A. Kushida, MD, PhD Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Shaun Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
Zaina Qureshi Zaina Qureshi has received personal compensation for serving as an employee of Merck.
Samantha K. Holden, MD, MS, FAAN Dr. Holden has nothing to disclose.
James P. Maynard, MD Dr. Maynard has nothing to disclose.
Susana Lopez Gallardo No disclosure on file
Roman Skowronski, MD, PhD Dr. Skowronski has nothing to disclose.
Nicole Goldberg-Boltz Miss Goldberg-Boltz has nothing to disclose.
Phyllis C. Zee, MD, PhD Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Craig Davis, PhD Dr. Davis has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Davis has received stock or an ownership interest from Harmony Biosciences.
Brice V. McConnell, MD The institution of Dr. McConnell has received research support from American Academy of Neurology.
Craig Chepke Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Craig Chepke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Craig Chepke has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Otsuka. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Takeda. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Janssen. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ironshore. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intracellular. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Craig Chepke has received research support from Acadia. Craig Chepke has received research support from Harmony. Craig Chepke has received research support from Neurocrine.
Hector Gonzalez No disclosure on file
Jeffrey M. Dayno, MD Dr. Dayno has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Dayno has received stock or an ownership interest from Harmony Biosciences.
Alon Y. Avidan, MD, MPH, FAAN Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Shafali Jeste, MD, FAAN Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Jordan S. Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Maurice M. Ohayon, MD, PhD, DSc The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
LynnMarie Trotti, MD Dr. Trotti has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Academy of Sleep Medicine. Dr. Trotti has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Association of Chest Physicians. The institution of Dr. Trotti has received research support from NIH. The institution of Dr. Trotti has received research support from American Academy of Sleep Medicine Foundation . Dr. Trotti has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with AASM, CHEST, Medscape, SRS Foundation, PER CME, Haymarket CME. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a Reviewer with Lancet journals. Dr. Trotti has a non-compensated relationship as a Medical advisory board member with Hypersomnia Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with AASM Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with ABSM that is relevant to AAN interests or activities.
Lindsay J. Howard Ms. Howard has nothing to disclose.
Yo-El Ju, MD The institution of Dr. Ju has received research support from National Institutes of Health.
William C. Winter Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Harmony Bioscience. Mr. Winter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Mr. Winter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Harmony Bioscience. Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Advisor with TempurPEDIC. Mr. Winter has received personal compensation in the range of $100,000-$499,999 for serving as a Advisor with MattressFirm.
Erik K. St. Louis, MD Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Divya S. Nadkarni, MD Dr. Nadkarni has nothing to disclose.
Maeve M. Pascoe Ms. Pascoe has nothing to disclose.
Sejal V. Jain, MD Dr. Jain has nothing to disclose.
Dara S. Manoach, MD The institution of Dr. Manoach has received research support from NIMH. The institution of Dr. Manoach has received research support from MGH ECOR.
Dawn Kellar No disclosure on file
Robert P. Rubens, MD, MBA, FAAN Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Albena I. Patroneva, MD Dr. Patroneva has nothing to disclose.
Jennifer S. McLeland Ms. McLeland has nothing to disclose.
Josiane Broussard No disclosure on file
Martha Daviglus No disclosure on file
Michael J. Thorpy, MD Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Judi Profant, PhD No disclosure on file
Stuart McCarter, MD Dr. McCarter has nothing to disclose.
Mark Boulos, MD Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Labs. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Jazz Pharmaceuticals.
Nancy R. Foldvary-Schaefer, DO, FAAN Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Genevieve Meier Genevieve Meier has received personal compensation for serving as an employee of Eisai.
Joaquin Ojeda, MD Dr. Ojeda has nothing to disclose.
Robert Alexander, MD Dr. Alexander has received personal compensation for serving as an employee of Takeda .
Catherine Tegeler Ms. Tegeler has nothing to disclose.
Linda Gallo No disclosure on file
Charles H. Tegeler, MD Dr. Tegeler has nothing to disclose.
David J. Seiden, MD Dr. Seiden has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Dr. Seiden has received stock or an ownership interest from Avadel Pharmaceuticals.
Thomas Roth, PhD Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz.
Caroline Maness, MD Dr. Maness has nothing to disclose.
Brian Berman, MD, MS, FAAN Dr. Berman has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for International Parkinson and Movement Disorder Society. The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from Administration for Community Living. The institution of Dr. Berman has received research support from The Parkinson Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Kathy K. Xiong, MD Miss Xiong has nothing to disclose.